Centric Medical receives FDA 510(k) clearance for implant system for foot, ankle
Click Here to Manage Email Alerts
Centric Medical, a division of Life Spine Inc., announced it has received FDA 510(k) clearance to market its Subtalar Arthroereisis Implant System for the treatment of foot hyperpronation and stabilization of the subtalar joint.
According to a company press release, the one-piece titanium implant is designed to correct pathologic flatfoot deformities by blocking forward, downward and medial displacement of the talus and allows for normal articulation of the subtalar joint. The implant system is expected to be released for limited time at the end of 2016 and full product release is expected in the first quarter of 2017.
Reference: